CoChat

Cardiac spheroids as promising in vitro models to study the human heart microenvironment

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Three-dimensional in vitro cell systems are a promising alternative to animals to study cardiac biology and disease. We have generated three-dimensional in vitro models of the human heart (“cardiac spheroids”, CSs) by co-culturing human primary or iPSC-derived cardiomyocytes, endothelial cells and fibroblasts at ratios approximating those present in vivo. The cellular organisation, extracellular matrix and microvascular network mimic human heart tissue. These spheroids have been employed to investigate the dose-limiting cardiotoxicity of the common anti-cancer drug doxorubicin. Viability/cytotoxicity assays indicate dose-dependent cytotoxic effects, which are inhibited by the nitric oxide synthase (NOS) inhibitor L-NIO, and genetic inhibition of endothelial NOS, implicating peroxynitrous acid as a key damaging agent. These data indicate that CSs mimic important features of human heart morphology, biochemistry and pharmacology in vitro, offering a promising alternative to animals and standard cell cultures with regard to mechanistic insights and prediction of toxic effects in human heart tissue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-06385-8

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation of cardiac spheroids in hanging drop culture. (a) Representative bright-field images of human primary cardiomyocytes (hCM), iPS-derived cardiac fibroblasts (iCF) and human coronary artery endothelial cells (ECs) co-cultured in hanging drops for 0, 2, 6, 12 and 24 h. (b) Representative bright-field images of hiPS-derived cardiomyocytes (iCM), iCF and ECs in hanging drop co-cultures after 0, 12, 24, 48 and 96 h. Scale bars: 100 μm. See also Figs S1, S2 and Videos S1 and S2.
Figure 1 Generation of cardiac spheroids in hanging drop culture. (a) Representative bright-field images of human primary cardiomyocytes (hCM), iPS-derived cardiac fibroblasts (iCF) and human coronary artery endothelial cells (ECs) co-cultured in hanging drops for 0, 2, 6, 12 and 24 h. (b) Representative bright-field images of hiPS-derived cardiomyocytes (iCM), iCF and ECs in hanging drop co-cultures after 0, 12, 24, 48 and 96 h. Scale bars: 100 μm. See also Figs S1, S2 and Videos S1 and S2.CC BY · PubMed Central
Figure 2 Sorting of cardiomyocytes, endothelial cells and fibroblasts within cardiac spheroids. (a–d) PECAM-positive ECs (blue) form a microvascular network within hCSs (a,b) and iCSs (c,d) in hanging drop cultures. Vimentin-positive iCFs (green) sort out both on the surface and within hCSs (a,b) and iCSs (c,d). Cardiac Troponin T-positive iCMs (red) are surrounded by both ECs and iCFs in hCSs (a,b) and iCSs (c,d). Scale bars: 100 μm in (a,b), 200 μm in (c,d). See also Fig. S3.
Figure 2 Sorting of cardiomyocytes, endothelial cells and fibroblasts within cardiac spheroids. (a–d) PECAM-positive ECs (blue) form a microvascular network within hCSs (a,b) and iCSs (c,d) in hanging drop cultures. Vimentin-positive iCFs (green) sort out both on the surface and within hCSs (a,b) and iCSs (c,d). Cardiac Troponin T-positive iCMs (red) are surrounded by both ECs and iCFs in hCSs (a,b) and iCSs (c,d). Scale bars: 100 μm in (a,b), 200 μm in (c,d). See also Fig. S3.CC BY · PubMed Central
Figure 3 Extracellular matrix (ECM) deposition ex vivo and in vitro. Fibronectin (a), collagen type IV (b) and laminin (c) deposition within human heart sections, hCSs and iCSs (green). Nuclei are stained with Hoechst stain (blue). Scale bars: 200 μm.
Figure 3 Extracellular matrix (ECM) deposition ex vivo and in vitro. Fibronectin (a), collagen type IV (b) and laminin (c) deposition within human heart sections, hCSs and iCSs (green). Nuclei are stained with Hoechst stain (blue). Scale bars: 200 μm.CC BY · PubMed Central
Figure 4 Inhibition of nitric oxide synthesis prevents DOX-mediated cardiotoxic effects in hCSs and iCSs. (a) Statistical analysis (n = 6) of DOX-mediated cardiotoxic effects in hCSs and iCSs evaluated as a ratio between dead and live cells after 24 h treatment. 100 μM L-NIO prevents the doxorubicin-mediated effects in both hCSs and iCSs treated with 10, 20 and 40 μM doxorubicin. (b) Statistical analysis (n = 6) of DAF-FM-positive cells in hCSs and iCSs following 24 h doxorubicin treatment. *Relative to control for all groups; ♯Within the same concentration. Data are presented as mean ± SEM. One-way ANOVA followed by Bonferroni’s multiple comparisons test. F (df 10, 55)=40.53 for (a) hCS, F (df 10, 143) = 253 for (a) iCS, F (5, 30) = 37.33 (b) hCS and F (5, 30)=56.09 for (b) iCS. See also Fig. S4.
Figure 4 Inhibition of nitric oxide synthesis prevents DOX-mediated cardiotoxic effects in hCSs and iCSs. (a) Statistical analysis (n = 6) of DOX-mediated cardiotoxic effects in hCSs and iCSs evaluated as a ratio between dead and live cells after 24 h treatment. 100 μM L-NIO prevents the doxorubicin-mediated effects in both hCSs and iCSs treated with 10, 20 and 40 μM doxorubicin. (b) Statistical analysis (n = 6) of DAF-FM-positive cells in hCSs and iCSs following 24 h doxorubicin treatment. *Relative to control for all groups; ♯Within the same concentration. Data are presented as mean ± SEM. One-way ANOVA followed by Bonferroni’s multiple comparisons test. F (df 10, 55)=40.53 for (a) hCS, F (df 10, 143) = 253 for (a) iCS, F (5, 30) = 37.33 (b) hCS and F (5, 30)=56.09 for (b) iCS. See also Fig. S4.CC BY · PubMed Central
Figure 5 Doxorubicin-mediated apoptosis is inhibited by L-NIO. (a) Confocal analysis of hCSs and iCSs cultured with and without 20 μM DOX and 100 μM L-NIO and stained with antibodies against active caspase 3 (shown in red). (b) Statistical analysis (n = 3) of black-versus-white ratios of confocal images of hCSs and iCSs cultured and stained as described in panel (a). Data are presented as mean ± SEM. Scale bars: 200 μm. One-way ANOVA followed by Bonferroni’s multiple comparisons test. F (df 5, 12) = 1.153.
Figure 5 Doxorubicin-mediated apoptosis is inhibited by L-NIO. (a) Confocal analysis of hCSs and iCSs cultured with and without 20 μM DOX and 100 μM L-NIO and stained with antibodies against active caspase 3 (shown in red). (b) Statistical analysis (n = 3) of black-versus-white ratios of confocal images of hCSs and iCSs cultured and stained as described in panel (a). Data are presented as mean ± SEM. Scale bars: 200 μm. One-way ANOVA followed by Bonferroni’s multiple comparisons test. F (df 5, 12) = 1.153.CC BY · PubMed Central
Figure 6 DOX toxicity is mediated via NOS in different cell types. (a) Comparison of DOX-mediated toxic effects in co-cultures from different cell populations (n = 6): (i) iCS generated from iCM, EC and iCF; (ii) iCMs combined with ECs only; (iii) iCMs combined with iCFs only; and iv) ECs combined with iCFs. 100 μM L-NIO was used to inhibit NOS activity. Two-way ANOVA followed by Tukey’s multiple comparisons test. F (df 7, 32) = 17.13. (b) Comparison of DOX-mediated toxicity in iCSs where eNOS was inhibited by using eNOS shRNA in specific cell types (n = 6). Scramble shRNA was used as control. *Relative to iCS; ♯within the same cell population. Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s multiple comparisons test. F (df 4, 40) = 5.846.
Figure 6 DOX toxicity is mediated via NOS in different cell types. (a) Comparison of DOX-mediated toxic effects in co-cultures from different cell populations (n = 6): (i) iCS generated from iCM, EC and iCF; (ii) iCMs combined with ECs only; (iii) iCMs combined with iCFs only; and iv) ECs combined with iCFs. 100 μM L-NIO was used to inhibit NOS activity. Two-way ANOVA followed by Tukey’s multiple comparisons test. F (df 7, 32) = 17.13. (b) Comparison of DOX-mediated toxicity in iCSs where eNOS was inhibited by using eNOS shRNA in specific cell types (n = 6). Scramble shRNA was used as control. *Relative to iCS; ♯within the same cell population. Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s multiple comparisons test. F (df 4, 40) = 5.846.CC BY · PubMed Central
Figure 7 Cross-talk between different cell types in DOX-induced cardiotoxicity. (a) DOX-induced effects on cardiomyocytes occurs via ROS/caspase 3-mediated apoptosis. (b) EC-released NO protects cardiomyocytes against DOX-induced toxicity. (c) DOX-induced eNOS up-regulation in endothelial cells produces toxic NO species. (d) DOX-induced eNOS up-regulation in cardiac fibroblasts produces the majority of the toxic NO species. (e) DOX-induced cardiotoxic effects via ROS production in cardiac fibroblasts. At the molecular level, DOX/superoxide-induced apoptosis in cardiomyocytes can be either rescued by endothelial cell-released NO, via inhibition of a ROS-mediated toxic effect, or can be exacerbated by increased eNOS expression and peroxynitrous acid formation. Cardiac fibroblasts can trigger DOX/NO-toxic effects by overexpressing eNOS and increasing peroxynitrous acid generation, or could increase superoxide levels and therefore feedback to endothelial cell-mediated peroxynitrous acid and cardiomyocyte apoptosis.
Figure 7 Cross-talk between different cell types in DOX-induced cardiotoxicity. (a) DOX-induced effects on cardiomyocytes occurs via ROS/caspase 3-mediated apoptosis. (b) EC-released NO protects cardiomyocytes against DOX-induced toxicity. (c) DOX-induced eNOS up-regulation in endothelial cells produces toxic NO species. (d) DOX-induced eNOS up-regulation in cardiac fibroblasts produces the majority of the toxic NO species. (e) DOX-induced cardiotoxic effects via ROS production in cardiac fibroblasts. At the molecular level, DOX/superoxide-induced apoptosis in cardiomyocytes can be either rescued by endothelial cell-released NO, via inhibition of a ROS-mediated toxic effect, or can be exacerbated by increased eNOS expression and peroxynitrous acid formation. Cardiac fibroblasts can trigger DOX/NO-toxic effects by overexpressing eNOS and increasing peroxynitrous acid generation, or could increase superoxide levels and therefore feedback to endothelial cell-mediated peroxynitrous acid and cardiomyocyte apoptosis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 236

Metadata

Authors
Polonchuk, L., Chabria, M., Badi, L., Hoflack, J.-C., Figtree, G., Davies, M. J., & Gentile, C.
Affiliations
  • F. Hoffmann-La Roche AG (CH)
  • The University of Sydney (AU)
  • University of Copenhagen (DK)
Corresponding author
Gentile, Carmine
Venue
Scientific Reports
Published
2017-08-01
Volume
7
Issue
1
Pages
7005-7005
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2737012672
Cited by
223
References
64
Citations by year
2026: 18 · 2025: 20 · 2024: 22 · 2023: 28 · 2022: 33 · 2021: 50 · 2020: 28 · 2019: 11 · 2018: 11 · 2017: 1
FWCI
10.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Adobe Systems
  • Heart Research Institute
  • Novo Nordisk (NNF13OC0004294)
  • Novo Nordisk Fonden (NNF13OC0004294)
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
cardiac spheroids, 3D in vitro model, iPSC-derived cardiomyocytes, extracellular matrix, microvascular networks, doxorubicin cardiotoxicity, nitric oxide synthase, endothelial NOS, peroxynitrous acid, alternatives to animal testing, cardiotoxicity prediction
MeSH terms
Antineoplastic Agents, Cell Survival, Doxorubicin, Fibroblasts, Heart, Humans, Models, Biological, Spheroids, Cellular, Myocytes, Cardiac, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiac spheroids as promising in vitro models to study the human heart microenvironment. https://app.cochat.ai/papers/10.1038/s41598-017-06385-8
The paper
Polonchuk, L., Chabria, M., Badi, L., Hoflack, J.-C., Figtree, G., Davies, M. J., & Gentile, C. (2017). Cardiac spheroids as promising in vitro models to study the human heart microenvironment. Scientific Reports. https://doi.org/10.1038/s41598-017-06385-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.